Safer Drug Use (ECR552)
The proposal consists of 7 components and would commence from 1 July 2022.
Component 1 would fund a scoping study to determine the areas of greatest need and types of services, and suitable locations for new medically supervised injecting centres (the centres) in Australian capital cities.
Component 2 would establish one new centre in each capital city. Funding would be ongoing.
Read moreSafer Drug Use (ECR552)
The proposal consists of 7 components and would commence from 1 July 2022.
Component 1 would fund a scoping study to determine the areas of greatest need and types of services, and suitable locations for new medically supervised injecting centres (the centres) in Australian capital cities.
Component 2 would establish one new centre in each capital city. Funding would be ongoing.
Read moreSafer Drug Use (ECR552)
The proposal consists of 7 components and would commence from 1 July 2022.
Component 1 would fund a scoping study to determine the areas of greatest need and types of services, and suitable locations for new medically supervised injecting centres (the centres) in Australian capital cities.
Component 2 would establish one new centre in each capital city. Funding would be ongoing.
Read moreSafer Drug Use (ECR552)
The proposal consists of 7 components and would commence from 1 July 2022.
Component 1 would fund a scoping study to determine the areas of greatest need and types of services, and suitable locations for new medically supervised injecting centres (the centres) in Australian capital cities.
Component 2 would establish one new centre in each capital city. Funding would be ongoing.
Read moreSafer Drug Use (ECR552)
The proposal consists of 7 components and would commence from 1 July 2022.
Component 1 would fund a scoping study to determine the areas of greatest need and types of services, and suitable locations for new medically supervised injecting centres (the centres) in Australian capital cities.
Component 2 would establish one new centre in each capital city. Funding would be ongoing.
Read moreSafer Drug Use (ECR552)
The proposal consists of 7 components and would commence from 1 July 2022.
Component 1 would fund a scoping study to determine the areas of greatest need and types of services, and suitable locations for new medically supervised injecting centres (the centres) in Australian capital cities.
Component 2 would establish one new centre in each capital city. Funding would be ongoing.
Read moreSafer Drug Use (ECR552)
The proposal consists of 7 components and would commence from 1 July 2022.
Component 1 would fund a scoping study to determine the areas of greatest need and types of services, and suitable locations for new medically supervised injecting centres (the centres) in Australian capital cities.
Component 2 would establish one new centre in each capital city. Funding would be ongoing.
Read moreDouble the value of corporate penalties for misuse of market power (ECR572)
The proposal would double the value of penalties corporations face for the misuse of market power.
The proposal would commence from 1 July 2022.
Read moreDouble the value of corporate penalties for misuse of market power (ECR572)
The proposal would double the value of penalties corporations face for the misuse of market power.
The proposal would commence from 1 July 2022.
Read moreDouble the value of corporate penalties for misuse of market power (ECR572)
The proposal would double the value of penalties corporations face for the misuse of market power.
The proposal would commence from 1 July 2022.
Read morePagination
- Previous page
- Page 8
- Next page